NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo a dramatic transformation. From the spire of One World Trade Center in New York City to the mist-shrouded heights of Niagara Falls and the architectural peaks of the Mactan-Cebu Airport in the Philippines, more than 325 landmarks across 20 countries will be bathed in a specific tri-color palette: teal, green, and pink.
This coordinated display marks the highlight of National Metastatic Breast Cancer Awareness Day. Orchestrated by METAvivor Research and Support, the #LightUpMBC campaign is a global initiative designed to pull the veil back on the often-overlooked reality of Stage 4 breast cancer. While October is traditionally synonymous with "pink ribbon" awareness and messages of early detection, #LightUpMBC focuses on the 30% of breast cancer patients whose disease spreads beyond the breast, for whom there is currently no cure.
Main Facts: A Global Beacon for Research
The 2026 #LightUpMBC campaign represents the largest coordinated effort in the history of metastatic breast cancer (MBC) advocacy. Spanning all 50 U.S. states and involving 195 cities, the initiative seeks to achieve two primary goals: honoring the lives lost to the disease and raising critical funds for scientific research.
Metastatic breast cancer, also known as Stage 4, occurs when cancer cells break away from the primary tumor and travel through the lymphatic system or bloodstream to distant organs, most commonly the bones, liver, lungs, or brain. Unlike early-stage breast cancer, which can often be treated with curative intent, MBC requires lifelong treatment.
The centerpiece of the day’s activities is #LightUpMBC Live, a free virtual broadcast streaming at 8 p.m. ET. The program serves as a bridge between the clinical world and the patient community, featuring testimonials from those living with the disease, insights from leading oncologists, and performances by world-renowned artists. Crucially, METAvivor has maintained a steadfast commitment to its financial model: 100% of the net proceeds from the campaign and the livestream are funneled directly into Stage 4 research grants.
Chronology: From a Single Bridge to a Global Movement
The origins of #LightUpMBC are rooted in personal loss and a grassroots desire for visibility. The campaign was inspired by Jessica Moore, a young woman diagnosed with MBC who passed away in 2017 at the age of 36. Moore’s original wish was modest: to see one local landmark lit in the MBC awareness colors to acknowledge those living with the terminal form of the disease.
In 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to fulfill this wish. Under the leadership of Laura Inahara, Moore’s best friend and the founder of #LightUpMBC, the movement began to scale rapidly.
- 2013: Dr. Kelly Shanahan, a physician, is diagnosed with metastatic breast cancer, eventually joining the METAvivor board to advocate for research-focused funding.
- 2017: The inaugural lighting takes place in New Hampshire, sparking the #LightUpMBC movement.
- 2018–2022: The campaign expands from a handful of regional landmarks to over 100 sites across North America.
- 2023–2025: International participation surges, with landmarks in Europe, Asia, and South America joining the cause. The campaign surpasses the $2 million mark in total funds raised for research.
- October 13, 2026: The current iteration reaches a record-breaking 325+ landmarks, solidifying its status as a premier global health awareness event.
The 2026 broadcast will be hosted by Tami Eagle Bowling, a creator and advocate who has lived with MBC for 11 years, alongside Broadway star Kara Lindsay. This year’s event also marks a significant milestone in fundraising, with the campaign having generated over $2.7 million for research to date.
Supporting Data: The Statistical Urgency of Stage 4 Research
The necessity of the #LightUpMBC campaign is underscored by sobering statistics provided by the National Cancer Institute and the American Cancer Society.
In 2026, an estimated 42,670 people in the United States alone are expected to succumb to breast cancer. This averages out to approximately 117 deaths every single day. Nearly all of these deaths are the result of metastasis. Despite these figures, historical data suggests that only a small fraction of overall breast cancer research funding—estimated by some advocacy groups to be as low as 7% to 10%—is directed specifically toward understanding and treating metastatic disease.
The Reality of MBC Survival and Diagnosis:
- De Novo Diagnosis: Approximately 6% of new breast cancer cases in the U.S. are "de novo," meaning the cancer has already metastasized at the time of the initial diagnosis.
- Recurrence: For the remaining majority, MBC develops months or even decades after the patient has completed treatment for early-stage (Stage 1-3) cancer and was told they were "cancer-free."
- Treatment Resistance: While new therapies have extended the lives of MBC patients, the cancer eventually becomes resistant to specific drugs, necessitating a constant rotation of treatments.
METAvivor’s role is unique because it exclusively funds Stage 4 research. The organization utilizes a rigorous peer-review process that includes both scientific experts and patient advocates to ensure that the projects funded have the highest potential for immediate impact on patient longevity and quality of life.
Official Responses: Leadership and Advocacy
The leadership of METAvivor and the founders of the campaign emphasize that while the lights are a beautiful tribute, the ultimate goal is the science they fund.
“When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later,” said Dr. Kelly Shanahan, METAvivor Board President. “My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community.”
Laura Inahara, the founder of the campaign, reflected on the legacy of the woman who started it all. “Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research.”
The 2026 livestream will feature a heavy emphasis on the "human" side of these statistics. Performers such as two-time Tony Award winner Victoria Clark and Tony Award nominee Dorian Harewood will join the broadcast to lend their voices to the cause, highlighting the intersection of art, advocacy, and science.
Implications: Shifting the Narrative from Awareness to Action
The #LightUpMBC campaign is more than a visual spectacle; it represents a paradigm shift in how the public perceives breast cancer. For decades, the "pink" movement has focused heavily on mammography and early detection. While these are vital for public health, they often leave those with Stage 4 disease feeling marginalized or blamed for their condition.
1. Changing the Medical Outlook:
The long-term implication of METAvivor’s funding is the transformation of MBC from a terminal diagnosis into a manageable chronic condition. By funding research into why cancer cells migrate and how they develop resistance to therapy, the organization aims to give patients "more time"—a goal that resonates deeply with the 117 families who lose a loved one every day.
2. Global Advocacy and Policy:
The involvement of international landmarks like the Ness Bridge in Scotland and the Willis Tower in Chicago signals a growing global consensus that metastatic research requires its own dedicated funding stream. As the campaign grows, it exerts pressure on national health organizations to re-evaluate their own research allocations.
3. Patient Empowerment:
By featuring patient stories live from illuminated landmarks, the campaign provides a platform for a population that often feels invisible during Breast Cancer Awareness Month. This visibility encourages patients to become "advocates in the exam room," staying informed about the latest clinical trials and research breakthroughs.
As October 13 approaches, the public is encouraged to participate by photographing their local illuminated landmarks and sharing them via social media using the hashtags #LightUpMBC and #METAvivor. In doing so, they contribute to a global digital tapestry that demands more for those living with Stage 4 disease.
For a full list of participating landmarks and to access the livestream on October 13, visit www.lightupmbc.org.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) nonprofit organization dedicated to the specific fight against Stage 4 metastatic breast cancer. It is the only U.S. organization of its kind to dedicate 100% of its net donations to MBC research. Through its mission, METAvivor seeks to ensure that one day, no one dies from breast cancer.
About the Author
